Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -29.61% vs 6.45% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 1,013.54% vs -1.03% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 50.19% vs 42.06% in Mar 2025
Compare Balance Sheet Results of Asston Pharmaceu
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
8.51
26.09
-17.58
-67.38%
Share Warrants & Outstandings
Total Reserve
30.35
42.89
-12.54
-29.24%
Shareholder's Funds
38.86
68.99
-30.13
-43.67%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.55
6.22
-2.67
-42.93%
Secured Loans
3.17
6.22
-3.05
-49.04%
Unsecured Loans
0.38
0.00
0.38
0.00%
Deferred Tax Assets / Liabilities
0.08
-0.15
0.23
153.33%
Other Long Term Liabilities
0.16
0.00
0.16
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.29
-0.29
-100.00%
Total Non-Current Liabilities
3.79
5.82
-2.03
-34.88%
Current Liabilities
Trade Payables
5.76
21.18
-15.42
-72.80%
Other Current Liabilities
1.68
14.03
-12.35
-88.03%
Short Term Borrowings
1.55
12.84
-11.29
-87.93%
Short Term Provisions
0.00
0.25
-0.25
-100.00%
Total Current Liabilities
8.99
48.30
-39.31
-81.39%
Total Liabilities
51.65
123.11
-71.46
-58.05%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
11.05
3.93
7.12
181.17%
Less: Accumulated Depreciation
0.36
2.49
-2.13
-85.54%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
10.69
1.44
9.25
642.36%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.25
-0.25
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
5.43
-5.43
-100.00%
Long Term Loans & Advances
0.38
1.14
-0.76
-66.67%
Other Non Current Assets
0.00
1.63
-1.63
-100.00%
Total Non-Current Assets
11.07
10.14
0.93
9.17%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.77
3.40
-2.63
-77.35%
Sundry Debtors
36.57
50.77
-14.20
-27.97%
Cash and Bank
1.29
1.43
-0.14
-9.79%
Other Current Assets
0.00
1.05
-1.05
-100.00%
Short Term Loans and Advances
1.95
56.31
-54.36
-96.54%
Total Current Assets
40.58
112.96
-72.38
-64.08%
Net Current Assets (Including Current Investments)
31.59
64.66
-33.07
-51.14%
Total Current Assets Excluding Current Investments
40.58
112.96
-72.38
-64.08%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
51.65
123.11
-71.46
-58.05%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
5.11
18.00
-12.89
-71.61%
Book Value per share (adjusted)
45.65
5.29
40.36
762.95%
Annual - Borrowings
Borrowings 5.11 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -29.61% vs 6.45% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.16 Cr
in Mar 2026Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 10.69 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 1,013.54% vs -1.03% in Mar 2025
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 40.58 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 50.19% vs 42.06% in Mar 2025
Footer loading
